Dose Ranging Study of Albiglutide in Japanese Subjects

Clinical trial NCT01098461 · COMPLETED

Trial details

NCT number: NCT01098461
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-04-01
Primary completion: 2011-05-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.